Abstract
A double-blind cross-over trial of emepronium bromide (Cetiprin) in nocturnal frequency of micturition in a group of elderly women living in their homes showed that the drug was superior to placebo in diminishing urinary frequency, though not every person benefited. It is suggested that the drug may alter the established habit of rising at night to pass urine. Side-effects were negligible. © 1969, British Medical Journal Publishing Group. All rights reserved.
Cite
CITATION STYLE
Brocklehurst, J. C., Dillane, J. B., Fry, J., & Armitage, P. (1969). Clinical Trial of Emepronium Bromide in Nocturnal Frequency of Old Age. British Medical Journal, 2(5651), 216–218. https://doi.org/10.1136/bmj.2.5651.216
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
